Healthpeak Properties Inc. (NYSE:PEAK) went down by -1.02% from its latest closing price compared to the recent 1-year high of $37.93. The company’s stock price has collected 1.69% of gains in the last five trading sessions. Press Release reported on 09/22/20 that Healthpeak Properties(TM) to Report Third Quarter 2020 Financial Results and Host Conference Call/Webcast
Is It Worth Investing in Healthpeak Properties Inc. (NYSE :PEAK) Right Now?
Healthpeak Properties Inc. (NYSE:PEAK) scored a price-to-earnings ratio above its average ratio, recording 44.34 x from its present earnings ratio. Plus, the 36-month beta value for PEAK is at 0.67. Opinions of the stock are interesting as 10 analysts out of 21 who provided ratings for Healthpeak Properties Inc. declared the stock was a “buy,” while 2 rated the stock as “overweight,” 9 rated it as “hold,” and 0 as “sell.”
The average price from analysts is $29.61, which is $2.17 above the current price. PEAK currently public float of 537.51M and currently shorts hold a 1.39% ratio of that float. Today, the average trading volume of PEAK was 3.53M shares.
PEAK’s Market Performance
PEAK stocks went up by 1.69% for the week, with a monthly drop of -4.95% and a quarterly performance of -1.85%, while its annual performance rate touched -24.08%. The volatility ratio for the week stands at 3.15% while the volatility levels for the past 30 days are set at 3.02% for Healthpeak Properties Inc.. The simple moving average for the period of the last 20 days is -1.91% for PEAK stocks with a simple moving average of -6.06% for the last 200 days.
Analysts’ Opinion of PEAK
Many brokerage firms have already submitted their reports for PEAK stocks, with Stifel repeating the rating for PEAK by listing it as a “Buy.” The predicted price for PEAK in the upcoming period, according to Stifel is $31 based on the research report published on September 02nd of the current year 2020.
PEAK Trading at -1.59% from the 50-Day Moving Average
After a stumble in the market that brought PEAK to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -28.68% of loss for the given period.
Volatility was left at 3.02%, however, over the last 30 days, the volatility rate increased by 3.15%, as shares sank -2.13% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +5.29% upper at present.
During the last 5 trading sessions, PEAK rose by +1.69%, which changed the moving average for the period of 200-days by -16.28% in comparison to the 20-day moving average, which settled at $27.55. In addition, Healthpeak Properties Inc. saw -21.53% in overturn over a single year, with a tendency to cut further losses.
Reports are indicating that there were more than several insider trading activities at PEAK starting from Lewis Sara Grootwassink, who purchase 3,000 shares at the price of $32.13 back on Feb 28. After this action, Lewis Sara Grootwassink now owns 3,000 shares of Healthpeak Properties Inc., valued at $96,377 using the latest closing price.
GARVEY CHRISTINE, the Director of Healthpeak Properties Inc., sale 550 shares at $36.98 during a trade that took place back on Feb 20, which means that GARVEY CHRISTINE is holding 22,805 shares at $20,340 based on the most recent closing price.
Stock Fundamentals for PEAK
Current profitability levels for the company are sitting at:
- +6.54 for the present operating margin
- +22.83 for the gross margin
The net margin for Healthpeak Properties Inc. stands at +2.20. The total capital return value is set at 1.03, while invested capital returns managed to touch 0.37. Equity return is now at value 4.90, with 2.20 for asset returns.
Based on Healthpeak Properties Inc. (PEAK), the company’s capital structure generated 106.95 points at debt to equity in total, while total debt to capital is 51.68. Total debt to assets is 46.38, with long-term debt to equity ratio resting at 105.36. Finally, the long-term debt to capital ratio is 50.91.
Currently, EBITDA for the company is 576.23M with total debt to EBITDA at 6.24. When we switch over and look at the enterrpise to sales, we see a ratio of 11.90, with the company’s debt to enterprise value settled at 0.27. The receivables turnover for the company is 37.13 and the total asset turnover is 0.15.